[1] 邹声泉. 胆道病学. 1版. 北京:人民卫生出版社,2010:793.
[2] Nathwani RA,Kaplowitz N. Drug Hepatotoxicity . Clin Liver Dis,2006,10:207-217.
[3] 梁扩寰,李绍白. 肝脏病学. 北京:人民卫生出版社,2003:786-790.
[4] ReauNS,Jensen DM. Vanishing bile duct syndrome . Clin Liver Dis,2008,12:203-217.
[5] Mohi-ud-din R,Lewis JH. Drug- and chemical-induced cholestasis. Clin Liver Dis,2004,8:95-132.
[6] Juricic D,Hrstic I,Radic D,et al. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man. Basic Clin Pharmacol Toxicol, 2010,106:62-5.
[7] 陈成伟.药物与中毒性肝病. 上海:上海科学技术出版社,2013:17-27.
[8] 许成勇,王发渭,孙志高等. 国内中草药致药物性肝损伤发生率的荟萃分析. 中国中医急症,2014,23:1988-1989.
[9] 孙玥,赵新颜,贾继东. 胆管消失综合征病因学诊断及预后进展. 肝脏,2014,19:137-138.
[10] Padda MS,Sanchez M,Akhtaretal AJ,et al. Drug-induced cholestasis. Hepatology,2011,53:1377-1387.
[11] 彭向欣,王泰龄. 肝脏疾病临床病理学. 北京:化学工业出版社,2010,245-246.
[12] 孙玥,赵新颜,贾继东. 药物相关性胆管消失综合征诊断及治疗进展.肝脏,2014,19:360-362.
[13] Gokce,S. Plasmapheresis in treatment of vanishing bile duct syndrome . J Pediatr Gastroenterol Nutr,2014,59:14. |
